T Cell Exhaustion and Downregulation of Cytotoxic NK Cells – an Immune Escape Mechanism in Adult Acute Lymphoblastic Leukemia
Éolia Brissot(Inserm), J. Carl Barrett(National Institute of Environmental Health Sciences), Amir T. Fathi(University of Southern California), B. Douglas Smith(Johns Hopkins University), Carly Cantilena(National Heart Lung and Blood Institute), Sawa Ito(National Institutes of Health), Stephen A. Strickland(Vanderbilt University), Hossein Sadrzadeh(Boston University), Christopher S. Hourigan(National Heart Lung and Blood Institute), Gabrielle T. Prince(Johns Hopkins University), Minoo Battiwalla(Sarah Cannon), Kit Lu(National Institutes of Health), Fariba Chinian(National Institutes of Health), Pawel Muranski(National Heart Lung and Blood Institute), Nancy F. Hensel(National Heart Lung and Blood Institute), Keyvan Keyvanfar(National Institutes of Health)
Cited by 3
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655